12-5044239-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002234.4(KCNA5):​c.92G>T​(p.Gly31Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00304 in 1,539,188 control chromosomes in the GnomAD database, including 111 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G31A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.015 ( 65 hom., cov: 33)
Exomes 𝑓: 0.0017 ( 46 hom. )

Consequence

KCNA5
NM_002234.4 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.437

Publications

3 publications found
Variant links:
Genes affected
KCNA5 (HGNC:6224): (potassium voltage-gated channel subfamily A member 5) Potassium channels represent the most complex class of voltage-gated ino channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. Four sequence-related potassium channel genes - shaker, shaw, shab, and shal - have been identified in Drosophila, and each has been shown to have human homolog(s). This gene encodes a member of the potassium channel, voltage-gated, shaker-related subfamily. This member contains six membrane-spanning domains with a shaker-type repeat in the fourth segment. It belongs to the delayed rectifier class, the function of which could restore the resting membrane potential of beta cells after depolarization and thereby contribute to the regulation of insulin secretion. This gene is intronless, and the gene is clustered with genes KCNA1 and KCNA6 on chromosome 12. Defects in this gene are a cause of familial atrial fibrillation type 7 (ATFB7). [provided by RefSeq, May 2012]
KCNA5 Gene-Disease associations (from GenCC):
  • atrial fibrillation, familial, 7
    Inheritance: AD Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial atrial fibrillation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017237067).
BP6
Variant 12-5044239-G-T is Benign according to our data. Variant chr12-5044239-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 309332.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.015 (2282/152344) while in subpopulation AFR AF = 0.0508 (2114/41588). AF 95% confidence interval is 0.049. There are 65 homozygotes in GnomAd4. There are 1108 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 2282 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNA5NM_002234.4 linkc.92G>T p.Gly31Val missense_variant Exon 1 of 1 ENST00000252321.5 NP_002225.2 P22460-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNA5ENST00000252321.5 linkc.92G>T p.Gly31Val missense_variant Exon 1 of 1 6 NM_002234.4 ENSP00000252321.3 P22460-1

Frequencies

GnomAD3 genomes
AF:
0.0150
AC:
2276
AN:
152226
Hom.:
65
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0508
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00660
Gnomad ASJ
AF:
0.00663
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000235
Gnomad OTH
AF:
0.0124
GnomAD2 exomes
AF:
0.00366
AC:
496
AN:
135632
AF XY:
0.00283
show subpopulations
Gnomad AFR exome
AF:
0.0516
Gnomad AMR exome
AF:
0.00257
Gnomad ASJ exome
AF:
0.00527
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000313
Gnomad OTH exome
AF:
0.00146
GnomAD4 exome
AF:
0.00173
AC:
2404
AN:
1386844
Hom.:
46
Cov.:
31
AF XY:
0.00152
AC XY:
1043
AN XY:
684660
show subpopulations
African (AFR)
AF:
0.0520
AC:
1649
AN:
31732
American (AMR)
AF:
0.00271
AC:
97
AN:
35782
Ashkenazi Jewish (ASJ)
AF:
0.00557
AC:
140
AN:
25152
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36002
South Asian (SAS)
AF:
0.000290
AC:
23
AN:
79286
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
36554
Middle Eastern (MID)
AF:
0.00353
AC:
17
AN:
4816
European-Non Finnish (NFE)
AF:
0.000230
AC:
248
AN:
1079670
Other (OTH)
AF:
0.00398
AC:
230
AN:
57850
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
157
313
470
626
783
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0150
AC:
2282
AN:
152344
Hom.:
65
Cov.:
33
AF XY:
0.0149
AC XY:
1108
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.0508
AC:
2114
AN:
41588
American (AMR)
AF:
0.00660
AC:
101
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00663
AC:
23
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000235
AC:
16
AN:
68026
Other (OTH)
AF:
0.0123
AC:
26
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
115
230
346
461
576
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00463
Hom.:
1
Bravo
AF:
0.0168
ESP6500AA
AF:
0.0335
AC:
129
ESP6500EA
AF:
0.000389
AC:
3
ExAC
AF:
0.00261
AC:
256
Asia WGS
AF:
0.00520
AC:
18
AN:
3476

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Atrial fibrillation, familial, 7 Benign:3
Nov 06, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:3
Sep 17, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 22, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Apr 08, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pulmonary arterial hypertension Benign:1
Sep 26, 2022
John Welsh Cardiovascular Diagnostic Laboratory, Baylor College of Medicine
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.24
CADD
Benign
17
DANN
Benign
0.97
DEOGEN2
Benign
0.21
T
Eigen
Benign
-0.87
Eigen_PC
Benign
-0.85
FATHMM_MKL
Benign
0.23
N
LIST_S2
Benign
0.48
T
MetaRNN
Benign
0.0017
T
MetaSVM
Uncertain
-0.24
T
MutationAssessor
Benign
0.55
N
PhyloP100
0.44
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
-0.58
N
REVEL
Benign
0.24
Sift
Benign
0.066
T
Sift4G
Benign
0.15
T
Polyphen
0.099
B
Vest4
0.083
MVP
0.99
MPC
0.70
ClinPred
0.0037
T
GERP RS
-0.27
PromoterAI
-0.018
Neutral
Varity_R
0.10
gMVP
0.34
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61737395; hg19: chr12-5153405; API